News

The S&P 500 Index ($SPX) (SPY) is up +1.15%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +1.09%, and the Nasdaq 100 ...
Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.75%, and the Nasdaq 100 Index ($IUXX) ...
In what one analyst described as an “unremarkable” outcome, the brain drug developer is being acquired for just $8.50 per ...
The deal comes at a time when Sage’s stock has demonstrated strong momentum, with InvestingPro data showing a 35% return in just the past week and a 68% year-to-date price return.
The stock rallied after the company announced that Supernus Pharmaceuticals has agreed to acquire Sage Therapeutics through a tender offer of $8.50 per share in cash, totaling around $561 million.
Sage Therapeutics SAGE underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below ... estimate of $8.50.
according to InvestingPro data. The price target adjustment follows Sage’s disclosure that Supernus Pharmaceuticals (NASDAQ:SUPN) has made an all-cash offer to acquire the company at $8.50 per ...
Sage Therapeutics SAGE announced that Supernus Pharmaceuticals SUPN has agreed to acquire SAGE through a tender offer of $8.50 per share in cash, totaling around $561 million. Additionally ...
The scheme does not assure or guarantee any returns. The Tata Nifty 50 Index Fund Regular Plan has an AUM of 1199.55 crores & has delivered CAGR of 20.79% in the last 5 years. The fund has an exit ...
The Axis Nifty 50 Index Fund Regular Growth has an AUM of 705.99 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 0.00% and an expense ratio of 0.42%.
Chelsea activate interest in Belgian wingerChelsea have officially opened dialogue with Olympique Lyonnais over a possible ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...